Search

Your search keyword '"Siegmund, T"' showing total 650 results
Start Over Author "Siegmund, T"
650 results on '"Siegmund, T"'

3. A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose

Author

Kress S, Borck A, Zisman A, Bramlage P, and Siegmund T

Subjects
basal-plus, prandial insulin, type-2 diabetes, glulisine, glargine, Specialties of internal medicine, RC581-951
Abstract

Stephan Kress,1 Anja Borck,2 Ariel Zisman,3 Peter Bramlage,4,5 Thorsten Siegmund6 1Diabeteszentrum, Vinzentius-Krankenhaus, Landau, Germany; 2Medical Department, Sanofi, Berlin, Germany; 3The Endocrine Center of Aventura, Aventura, FL, USA; 4Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany; 5Department for Angiology, Brandenburg Medical School, Campus Brandenburg/Havel, Brandenburg, Germany; 6Diabetes- Hormon- Und Stoffwechselzentrum Am Isar Klinikum München, München, GermanyCorrespondence: Stephan KressDiabeteszentrum, Vinzentius Krankenhaus, Cornichonstr. 4, Landau, 76829, GermanyTel +49 6341 172208Email kress.innere@vinzentius.deAim: In the present analysis, we characterised the efficacy and safety of adding a single daily injection of insulin glulisine to optimised basal-supported oral therapy (BOT) in patients with a high BeAM value, defined as a more than 50 mg/dl difference between bedtime and pre-breakfast blood glucose.Methods: The BeAM value was retrospectively calculated for patients pooled from two clinical trials that supplemented BOT with glulisine. Data regarding changes in HbA1c, fasting plasma glucose (FPG), and postprandial glucose (PPG) levels from observation periods of 3 to 6 months were assessed.Results: Out of 358 patients that received BOT/glulisine, 182 had a high BeAM value. Patients with a high BeAM value were older and had a longer diabetes duration than patients with a medium BeAM value. Significant reductions in HbA1c (7.5% to 7.2% [59 to 55 mmol/mol], p< 0.0001) and PPG (202 to 143 mg/dl, p< 0.0001) levels were documented. The proportion of patients with a high BeAM value achieving an HbA1c < 7% [53 mmol/mol], alone or in combination with no hypoglycaemia, was lower than that of patients with a medium BeAM value.Conclusion: The analysis indicates that the supplementation of BOT with a single daily injection of prandial insulin is safe and effective for reducing HbA1c and PPG levels in patients with a high BeAM value (more than 50 mg/dl). However, patients with a medium BeAM value also responded well, which suggests that they should also be considered candidates for this change in therapy.Keywords: basal-plus, prandial insulin, type-2 diabetes, glulisine, glargine

Published
2021

5. The ARGUS Vertex Trigger

Author

Koch, N., Kolander, M., Kolanoski, H., Siegmund, T., Bergter, J., Eckstein, P., Schubert, K. R., Waldi, R., Imhof, M., Ressing, D., Weiss, U., and Weseler, S.

Subjects
High Energy Physics - Experiment
Abstract

A fast second level trigger has been developed for the ARGUS experiment which recognizes tracks originating from the interaction region. The processor compares the hits in the ARGUS Micro Vertex Drift Chamber to 245760 masks stored in random access memories. The masks which are fully defined in three dimensions are able to reject tracks originating in the wall of the narrow beampipe of 10.5\,mm radius., Comment: gzipped Postscript, 27 pages

Published
1995
Full Text
View/download PDF

7. Nebenprodukte, Rückstände und Abfälle

Author

Kaltschmitt, M., Stampfer, K., Thrän, Daniela, Siegmund, T., Karras, T., Kaltschmitt, M., Stampfer, K., Thrän, Daniela, Siegmund, T., and Karras, T.

Abstract

Unter Rückständen, Nebenprodukten und Abfällen werden hier Stoffe bzw. Stoffströme organischer Herkunft (d. h. Biomasse) verstanden, die bei der Herstellung eines bestimmten (Haupt-)Produktes (meist produziert mit dem Ziel der stofflichen Nutzung primär für den Nahrungs- und / oder Futtermittelsektor bzw. zur stofflichen Nutzung beispielsweise in der Papier- oder Möbelindustrie) aus organischen, nachwachsenden Rohstoffen anfallen und aufgrund grundsätzlicher Überlegungen zur Bioenergiebereitstellung nutzbar sind. Ausgehend davon ist es das Ziel dieses Kapitels, einen Überblick über derartige organische Stoffströme zu geben. Dies inkludiert entsprechende holzartige Rückstands-, Nebenprodukts- und Abfallstoffströme (z. B. Altholz), potenziell verfügbare halmgut- und krautartige Stoffe aus der landwirtschaftlichen Primärproduktion und den entsprechenden nachgelagerten Weiterverarbeitungsprozessen bzw. Industrien sowie sonstige Biomassen, die dieser Stoffstromkategorie zuzuordnen sind; unter letzterer Kategorie werden hier u. a. Exkremente aus der Nutztierhaltung, organische Siedlungsabfälle und organisch belastete Abwässer (einschließlich Klärschlamm) verstanden.

Published
2023

8. Einleitung und Zielsetzung

Author

Kaltschmitt, M., Stampfer, K., Hartmann, H., Hofbauer, H., Schultz, J., Siegmund, T., Thrän, Daniela, Kaltschmitt, M., Stampfer, K., Hartmann, H., Hofbauer, H., Schultz, J., Siegmund, T., and Thrän, Daniela

Abstract

Dieses Kapitel gibt zunächst einen Überblick über die Biomasse als Energieträger und definiert hier wesentliche Grundbegriffe. Anschließend wird die heutige und zukünftige Rolle der Biomasse / der Bioenergie im globalen und europäischen Energiesystem diskutiert; dies inkludiert auch eine Analyse der vorhandenen Biomassepotenziale. Final wird dann der Aufbau der Buchreihe adressiert und die unterschiedlichen Buchteile / Kapitel entsprechend abgegrenzt.

Published
2023

9. Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study

Author

Pfohl M, Siegmund T, Pscherer S, Pegelow K, and Seufert J

Subjects
Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Martin Pfohl,1 Thorsten Siegmund,2 Stefan Pscherer,3 Katrin Pegelow,4 Jochen Seufert5 1Medizinische Klinik I, Evangelisches Bethesda-Klinikum GmbH, Duisburg, Germany; 2Städtisches Klinikum München GmbH, Klinikum Bogenhausen, III. Medizinische Abteilung, München, Germany; 3Klinisches Diabeteszentrum Südostbayern, Innere Medizin – Diabetologie, Traunstein, Germany; 4Sanofi-Aventis Deutschland GmbH, Berlin, Germany; 5Medizinische Universitätsklinik, Klinik für Innere Medizin II, Abteilung für Endokrinologie und Diabetologie, Freiburg, Germany Background: Due to the progressive nature of type 2 diabetes mellitus (T2DM), antidiabetic treatment needs to be continuously intensified to avoid long-term complications. In T2DM patients on either basal insulin-supported oral therapy (BOT) or supplementary insulin therapy (SIT) presenting with HbA1c values above individual targets for 3–6 months, therapy should be intensified. This study investigated effectiveness and tolerability of an intensification of BOT or SIT to a basal–bolus therapy (BBT) regimen in T2DM patients in daily clinical practice. Methods: This noninterventional, 8-month, prospective, multicenter study evaluated parameters of glucose control, occurrence of adverse events (eg, hypoglycemia), and acceptance of devices in daily clinical practice routine after 12 and 24 weeks of intensifying insulin therapy to a BBT regimen starting from either preexisting BOT with insulin glargine (pre-BOT) or preexisting SIT with ≥3 daily injections of insulin glulisine (pre-SIT). Results: A total of 1,530 patients were documented in 258 German medical practices. A total of 1,301 patients were included in the full analysis set (55% male, 45% female; age median 64 years; body mass index median 30.8 kg/m2; pre-BOT: n=1,072; pre-SIT: n=229), and 1,515 patients were evaluated for safety. After 12 weeks, HbA1c decreased versus baseline (pre-BOT 8.67%; pre-SIT 8.46%) to 7.73% and 7.66%, respectively (Δ mean -0.94% and -0.80%; P

Published
2015

29. Near-net-shape manufacturing of short fiber composite parts via discrete depositions

Author

Gunnerson, K.A., Cipra, R.J., and Siegmund, T.

Subjects
Textile fibers, Synthetic -- Production processes, Textile fibers, Synthetic -- Properties, Engineering and manufacturing industries, Science and technology
Abstract

A novel approach for the near-net-shape manufacturing of short fiber reinforced composite parts through robotic deposition of chopped fibers is presented. A device for the deposition of discrete packets of short fibers is developed. A simulation tool is described that predicts the optimal locations within a mold to deposit fibers from the deposition device in order to obtain composites with a uniform fiber density distribution within a part of complex perimeter geometry. The implementation of the deposition device in conjunction with a six-degree-of-freedom robot is described. Composite preforms are generated, and subsequently converted into composite parts via resin transfer molding. Mechanical testing was conducted on near-net-shape manufactured notched specimens and notched specimens machined from the bulk. Testing shows that the near-net-shape manufactured specimens possess at least equal stiffness and strength to those machined from the bulk. [DOI: 10.1115/1.2976122] Keywords: near-net-shape manufacturing, composite manufacturing, fiber deposition, discrete depositions, path planning

Published
2008

30. Two clinical cases of adjunctive use of a SGLT-2 inhibitor in type 1 diabetes

Author

Siegmund T, Ampudia-Blasco F, and Schnell O

Subjects
endocrine system diseases, nutritional and metabolic diseases
Abstract

Type 1 diabetes mellitus (T1DM) prevalence is increasing and despite all available modern treatment options, an overall small but noticeable increase of mean HbA1c was recently observed in various registries. Authorized adjunctive pharmacological treatment options to insulin therapy are still scarce for T1DM. In February 2019, the European Medicines Agency (EMA) approved dapagliflozin as first in class sodium/glucose co-transporter 2 inhibitor (SGLT-2i) adjunctive therapy to insulin in patients with T1DM, which is currently still not approved by the FDA in the United States. SGLT-2is have shown significant improvement in HbA1c, reducing body weight and increasing time-in-range by reducing glycaemic variability, as well as reductions in total daily insulin dose in the trials in persons with T1DM. The cases presented here translate some of the observations gained from clinical trials into a real-world environment. They demonstrate that even highly practised and educated patients can benefit from the addition of a SGLT-2i as adjunctive treatment to insulin in T1DM. In summary, these cases demonstrate that a variety of patients with T1DM in a real-world setting may benefit from SGLT-2i treatment, as they have the potential to improve HbA1c, excess of body weight and increasing TiR among other things. Copyright © 2020 Elsevier B.V. All rights reserved.

Published
2020

32. The roles of yield strength mismatch, interface strength, and plastic strain gradients in fatigue crack growth across interfaces

Author

Pribe, JD, Siegmund, T, Kruzic, JJ, Pribe, JD, Siegmund, T, and Kruzic, JJ

Abstract

An irreversible cohesive zone model was used to understand how plastic strain gradients and yield strength mismatches affect fatigue crack growth across bi-material and multilayer interfaces for a range of interface strengths. Parametric studies identified regimes of penetration through the interface, deflection into the interface, and a transition where cracks extend on both paths. Plastic strain gradients strongly influence the transition regime, and a yield strength mismatch is necessary to cause deflection. For crack growth across an interlayer, interactions between the interfaces occur when the crack-tip plastic zone spans the interlayer. Plastic strain gradients promote penetration through the interlayer.

Published
2020

41. Clinical benefits of switching to insulin degludec irrespective of previous basal insulin therapy in people with Type 1 or Type 2 diabetes: evidence from a European, multicentre, retrospective, non-interventional study (EU-TREAT)

Author

Knudsen, S.T. Lapolla, A. Schultes, B. Tentolouris, N. Catarig, A.-M. Wolden, M.L. Siegmund, T.

Abstract

Aims: To investigate whether the benefits of switching to insulin degludec observed in the European retrospective chart review study EU-TREAT were dependent on the previous basal insulin used. Methods: People with Type 1 or Type 2 diabetes were switched to insulin degludec from other basal insulins ≥6 months before data collection. Participants were stratified into three groups based on their previous basal insulin: insulin glargine 100 units/ml (Type 1: n=888; Type 2: n=259); insulin detemir (Type 1: n=726; Type 2: n=415); and neutral protamine Hagedorn (Type 1: n=53; Type 2: n=95). Their glycaemic control and hypoglycaemia incidence at 6 and 12 months post-switch vs pre-switch was then evaluated. Results: Significant HbA1c reductions were achieved in all previous basal insulin groups for participants with Type 1 diabetes [insulin glargine 100 units/ml: −2.08 mmol/mol (−0.19%); insulin detemir: −2.40 mmol/mol (−0.22%)] and those with Type 2 diabetes [insulin glargine 100 units/ml: −5.90 mmol/mol (–0.54%); insulin detemir: −6.01 mmol/mol (−0.55%); neutral protamine Hagedorn: −2.73 mmol/mol (−0.25%)] at 6 months, except for the relatively small neutral protamine Hagedorn group in those with Type 1 diabetes [−1.75 mmol/mol (−0.16%)], where statistical significance was not reached. At 6 months in the Type 1 diabetes group, switching to insulin degludec from insulin glargine 100 units/ml resulted in significantly lower hypoglycaemia rates across all hypoglycaemia categories; for the insulin detemir group, this significance was also observed for severe and nocturnal non-severe hypoglycaemia, while the low number of people in the neutral protamine Hagedorn group resulted in nonsignificant reductions in hypoglycaemia rates. At 6 months in the people with Type 2 diabetes, switching to insulin degludec resulted in significantly lower rates of hypoglycaemia across all categories for all groups. Similar outcomes were observed at 12 months. Conclusions: Switching to insulin degludec from other basal insulins can improve glycaemic control and/or reduce hypoglycaemia risk in people with diabetes (although there was a nonsignificant reduction in HbA1c and hypoglycaemia rates for the neutral protamine Hagedorn group in Type 1 diabetes) under routine care. © 2019 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK

Published
2019

43. A measurement of the electronic widths Γ ee of the ϒ(1S), ϒ(2S), and ϒ(4S) resonances, and of the total decay width Γ of the ϒ(4S)

Author

Albrecht, H., Hamacher, T., Hofmann, R. P., Kirchhoff, T., Mankel, R., Nau, A., Nowak, S., Reßing, D., Schröder, H., Schulz, H. D., Walter, M., Wurth, R., Hast, C., Kapitza, H., Kolanoski, H., Kosche, A., Lange, A., Lindner, A., Schieber, M., Siegmund, T., Spaan, B., Thurn, H., Töpfer, D., Wegener, D., Eckstein, P., Schmidtler, M., Schramm, M., Schubert, K. R., Schwierz, R., Waldi, R., Reim, K., Wegener, H., Eckmann, R., Kuipers, H., Mai, O., Mundt, R., Oest, T., Reiner, R., Schmidt-Parzefall, W., Funk, W., Stiewe, J., Werner, S., Ehret, K., Hofmann, W., Hüpper, A., Knöpfle, K. T., Spengler, J., Krieger, P., MacFarlane, D. B., Prentice, J. D., Saull, P. R. B., Tzamariudaki, K., Van de Water, R. G., Yoon, T. -S., Frankl, C., Schneider, M., Weseler, S., Kernel, G., Križan, P., Križnič, E., Podobnik, T., Živko, T., Balagura, V., Barsuk, S., Belyaev, I., Chistov, R., Danilov, M., Gershtein, L., Gershtein, Yu., Golutvin, A., Korolko, I., Kostina, G., Litvintsev, D., Pakhlov, P., Semenov, S., Snizhko, A., Tichomirov, I., Zaitsev, Yu., and ARGUS Collaboration

Published
1995
Full Text
View/download PDF

44. Measurement of the decay D*s2+(2573) → D0K+

Author

Albrecht, H., Hamacher, T., Hofmann, R. P., Kirchhoff, T., Mankel, R., Nau, A., Nowak, S., Reßing, D., Schröder, H., Schulz, H. D., Walter, M., Wurth, R., Hast, C., Kapitza, H., Kolanoski, H., Kosche, A., Lange, A., Lindner, A., Schieber, M., Siegmund, T., Spaan, B., Thurn, H., Töpfer, D., Wegener, D., Eckstein, P., Frankl, C., Graf, J., Schmidtler, M., Schramm, M., Schubert, K. R., Schwierz, R., Waldi, R., Reim, K., Wegener, H., Eckmann, R., Kuipers, H., Mai, O., Mundt, R., Oest, T., Reiner, R., Schmidt-Parzefall, W., Ehret, K., Hofmann, W., Hüpper, A., Knöpfle, K. T., Spengler, J., Krieger, P., MacFarlane, D. B., Prentice, J. D., Saull, P. R. B., Tzamariudaki, K., Van de Walter, R. G., Yoon, T. -S., Schneider, M., Weseler, S., Kernel, G., Križan, P., Križnič, E., Podobnik, T., Živko, T., Balagura, V., Barsuk, S., Bleyaev, I., Chistov, R., Danilov, M., Eiges, V., Gershtein, L., Gershtein, Yu, Golutvin, A., Korolko, I., Kostina, G., Litvintsev, D., Pakhlov, P., Semenov, S., Snizhko, A., Tichomirov, Lnn, Zaitsev, Yu, and ARGUS Collaboration

Published
1995
Full Text
View/download PDF

45. Tau decays into K* mesons

Author

Albrecht, H., Hamacher, T., Hofmann, R. P., Kirchhoff, T., Mankel, R., Nau, A., Nowak, S., Schröder, H., Schulz, H. D., Walter, M., Wurth, R., Hast, C., Kapitza, H., Kolanoski, H., Kosche, A., Lange, A., Lindner, A., Schieber, M., Siegmund, T., Spaan, B., Thurn, H., Töpfer, D., Wegener, D., Eckstein, P., Schubert, K. R., Schwierz, R., Waldi, R., Reim, K., Wegener, H., Eckmann, R., Kuipers, H., Mai, O., Mundt, R., Oest, T., Reiner, R., Schmidt-Parzefall, W., Stiewe, J., Werner, S., Ehret, K., Hofmann, W., Hüpper, A., Knöpfle, K. T., Spengler, J., Krieger, P., MacFarlane, D. B., Saull, P. R. B., Tzamariudaki, K., Van de Water, R. G., Yoon, T. -S., Frankl, C., Reßing, D., Schmidtler, M., Schneider, M., Weseler, S., Kernel, G., Križan, P., Križnič, E., Podobnik, T., Živko, T., Balagura, V., Belyaev, I., Schechelnitsky, S., Danilov, M., Doutskoy, A., Gershtein, Yu., Golutvin, A., Korolko, I., Kostina, G., Litvintsev, D., Lubimov, V., Pakhlov, P., Semenov, S., Snizhko, A., Tichomirov, I., Zaitsev, Yu., and ARGUS Collaboration

Published
1995
Full Text
View/download PDF

46. A search for the lepton-flavour violating decays τ → eα, τ → μα

Author

Albrecht, H., Hamacher, T., Hofmann, R. P., Kirchhoff, T., Mankel, R., Nau, A., Nowak, S., Reßing, D., Schröder, H., Schulz, H. D., Walter, M., Wurth, R., Hast, C., Kapitza, H., Kolanoski, H., Kosche, A., Lange, A., Lindner, A., Schieber, M., Siegmund, T., Spaan, B., Thurn, H., Töpfer, D., Wegener, D., Eckstein, P., Frankl, C., Graf, J., Schmidtler, M., Schramm, M., Schubert, K. R., Schwierz, R., Waldi, R., Reim, K., Wegener, H., Eckmann, R., Kuipers, H., Mai, O., Mundt, R., Oest, T., Reiner, R., Schmidt-Parzefall, W., Stiewe, J., Werner, S., Ehret, K., Hofmann, W., Hüpper, A., Knöpfle, K. T., Spengler, J., Kreger, P., MacFarlane, D. B., Prentice, J. D., Saull, P. R. B., Tzamariudaki, K., Van de Water, R. G., Yoon, T. -S., Schneider, M., Weseler, S., Kernel, G., Križnič, P., Podobnik, T., Živko, T., Balagura, V., Barsuk, S., Belyaev, I., Chistov, R., Danilov, M., Eiges, V., Gershtein, L., Gershtein, Yu., Golutvin, A., Igonkina, O., Korolko, I., Kostina, G., Litvintsev, D., Pakhlov, P., Semenov, S., Snizhko, A., Tichomirov, I., Zaitsev, Yu., and ARGUS Collaboration

Published
1995
Full Text
View/download PDF

47. Measurement of the decay fractions ofD * mesons

Author

Albrecht, H., Ehrlichmann, H., Hamacher, T., Hofmann, R. P., Kirchhoff, T., Mankel, R., Nau, A., Nowak, S., Reßing, D., Schröder, H., Schulz, H. D., Walter, M., Wurth, R., Hast, C., Kapitza, H., Kolanoski, H., Kosche, A., Lange, A., Lindner, A., Schieber, M., Siegmund, T., Spaan, B., Thurn, H., Töpfer, D., Wegener, D., Eckstein, P., Schmidtler, M., Schramm, M., Schubert, K. R., Schwierz, R., Waldi, R., Paulini, M., Reim, K., Wegener, H., Eckmann, R., Kuipers, H., Mai, O., Mundt, R., Oest, T., Reiner, R., Schmidt-Parzefall, W., Stiewe, J., Werner, S., Ehret, K., Hofmann, W., Hüpper, A., Khan, S., Knöpfle, K. T., Spengler, J., Krieger, P., MacFarlane, D. B., Prentice, J. D., Saull, P. R. B., Tzamariudaki, K., Van de Water, R. G., Yoon, T. -S., Frankl, C., Ratz, C., Schneider, M., Weseler, S., Kernel, G., Križan, P., Križnič, E., Podobnik, T., Živko, T., Balagura, V., Belyaev, I., Blinov, V., Chechelnitsky, S., Danilov, M., Droutskoy, A., Gershtein, Yu., Golutvin, A., Korolko, I., Kostina, G., Litvintsev, D., Lubimov, V., Pakhlov, P., Semenov, S., Snizhko, A., Tichomirov, I., Undrus, A., Zaitsev, Yu., Zhilich, V., and ARGUS Collaboration

Published
1995
Full Text
View/download PDF

48. Kaons in flavour taggedB decays

Author

Albrecht, H., Ehrlichmann, H., Hamacher, T., Hofmann, R. P., Kirchhoff, T., Nau, A., Nowak, S., Schröder, H., Schulz, H. D., Walter, M., Wurth, R., Hast, C., Kolanoski, H., Kosche, A., Lange, A., Lindner, A., Mankel, R., Schieber, M., Siegmund, T., Spaan, B., Thurn, H., Töpfer, D., Wegener, D., Bittner, M., Eckstein, P., Paulini, M. G., Reim, K., Wegener, H., Mundt, R., Oest, T., Reiner, R., Schmidt-Parzefall, W., Funk, W., Stiewe, J., Werner, S., Ehret, K., Hofmann, W., Hüpper, A., Khan, S., Knöpfle, K. T., Seeger, M., Spengler, J., Britton, D. I., Charlesworth, C. E. K., Edwards, K. W., Hyatt, E. R. F., Kapitza, H., Krieger, P., MacFarlane, D. B., Patel, P. M., Prentice, J. D., Saull, P. R. B., Tzamariudaki, K., Van de Water, R. G., Yoon, T. -S., Reßing, D., Schmidtler, M., Schneider, M., Schubert, K. R., Strahl, K., Waldi, R., Weseler, S., Kernel, G., Križan, P., Križnič, E., Podobnik, T., Živko, T., Cronström, H. I., Jönsson, L., Balagura, V., Belyaev, I., Chechelnitsky, S., Danilov, M., Droutskoy, A., Gershtein, Yu., Golutvin, A., Kostina, G., Litvintsev, D., Lubimov, V., Pakhlov, P., Ratnikov, F., Semenov, S., Snizhko, A., Soloshenko, V., Tichomirov, I., Zaitsev, Yu., and ARGUS Collaboration

Published
1994
Full Text
View/download PDF

49. Study ofD 0 andD + decays into final states with two or three kaons

Author

Albrecht, H., Hamacher, T., Hofmann, R. P., Kirchhoff, T., Mankel, R., Nau, A., Nowak, S., Reßing, D., Schröder, H., Schulz, H. D., Walter, M., Wurth, R., Hast, C., Kapitza, H., Kolanoski, H., Kosche, A., Lange, A., Lindner, A., Schieber, M., Siegmund, T., Spaan, B., Thurn, H., Töpfer, D., Wegener, D., Eckstein, P., Schmidtler, M., Schramm, M., Schubert, K. R., Schwierz, R., Waldi, R., Reim, K., Wegener, H., Eckmann, R., Kuipers, H., Mai, O., Mundt, R., Oest, T., Reiner, R., Schmidt-Parzefall, W., Stiewe, J., Werner, S., Ehret, K., Hofmann, W., Hüpper, A., Knöpfle, K. T., Spengler, J., Krieger, P., MacFarlane, D. B., Prentice, J. D., Saull, P. R. B., Tzamariudaki, K., Van de Water, R. G., Yoon, T. -S., Frankl, C., Schneider, M., Weseler, S., Kernel, G., Križan, P., Križnič, E., Podobnik, T., Živko, T., Balagura, V., Barsuk, S., Belyaev, I., Chechelnitsky, S., Chistov, R., Danilov, M., Droutskoy, A., Gershtein, Yu., Golutvin, A., Korolko, I., Kostina, G., Litvintsev, D., Lubimov, V., Pakhlov, P., Semenov, S., Snizhko, A., Tichomirov, I., Zaitsev, Yu., and ARGUS Collaboration

Published
1994
Full Text
View/download PDF

50. Inclusive production ofK *(892),ρ 0, andω(783) mesons in theϒ energy region

Author

Albrecht, H., Ehrlichmann, H., Hamacher, T., Hofmann, R. P., Kirchhoff, T., Nau, A., Nowak, S., Schröder, H., Schulz, H. D., Walter, M., Wurth, R., Hast, C., Kapitza, H., Kolanoski, H., Kosche, A., Lange, A., Lindner, A., Mankel, R., Schieber, M., Siegmund, T., Spaan, B., Thurn, H., Töpfer, D., Wegener, D., Bittner, M., Eckstein, P., Paulini, M., Reim, K., Wegener, H., Eckmann, R., Mundt, R., Oest, T., Reiner, R., Schmidt-Parzefall, W., Stiewe, J., Werner, S., Ehret, K., Hofmann, W., Hüpper, A., Khan, S., Knöpfle, K. T., Seeger, M., Spengler, J., Britton, D. I., Charlesworth, C. E. K., Edwards, K. W., Hvatt, E. R. F., Krieger, P., MacFarlane, D. B., Patel, P. M., Prentice, J. D., Saull, P. R. B., Tzamariudaki, K., Van de Water, R. G., Yoon, T. -S., Reßing, D., Schmidtler, M., Schneider, M., Schubert, K. R., Strahl, K., Waldi, R., Weseler, S., Kernel, G., Križan, P., Križnič, E., Podobnik, T., Živko, T., Balagura, V., Belyaev, I., Chechelnitsky, S., Danilov, M., Droutskoy, A., Gershtein, Yu., Golutvin, A., Korolko, I., Kostina, G., Litvintsev, D., Lubimov, V., Pakhlov, P., Semenov, S., Snizhko, A., Soloshenko, V., Tichomirov, I., Zaitsev, Yu., and ARGUS Collaboration

Published
1994
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results